The effect of warfarin treatment on renal plasminogen activator inhibitor-1 and tissue factor gene expression in a rat model of type 2 diabetic nephropathy.

被引：0
|
作者：
Hagiwara, H
Li, W
Watanabe, K
Seki, T
Uriu, K
Takagi, I
Ling, QY
Ariga, T
Okada, K
Kaizu, K
机构：
[1] Nihon Univ, Grad Sch Appl Life Sci, Dept Nutr & Physiol, Fujisawa, Kanagawa, Japan
[2] Univ Occupat & Environm Hlth, Kidney Ctr, Kitakyushu, Fukuoka 807, Japan
[3] Nihon Univ, Sch Med, Dept Internal Med 2, Tokyo 173, Japan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：391A / 391A
页数：1
相关论文
共 50 条
  • [31] Effects of Korean Red Ginseng extract on tissue plasminogen activator and plasminogen activator inhibitor-1 expression in cultured rat primary astrocytes
    Ko, Hyun Myung
    Joo, So Hyun
    Kim, Pitna
    Park, Jin Hee
    Kim, Hee Jin
    Bahn, Geon Ho
    Kim, Hahn Young
    Lee, Jongmin
    Han, Seol-Heui
    Shin, Chan Young
    Park, Seung Hwa
    JOURNAL OF GINSENG RESEARCH, 2013, 37 (04) : 401 - 412
  • [32] Expression of type-1 kidney plasminogen activator inhibitor in the of diabetic rat models
    Hagiwara, H
    Kaizu, K
    Uriu, K
    Noguchi, T
    Takagi, I
    Qie, YL
    Seki, T
    Ariga, T
    THROMBOSIS RESEARCH, 2003, 111 (4-5) : 301 - 309
  • [33] Hormonal Regulation of Expression of Tissue Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 in Cultured Rat Granulosa Cells
    刘以训
    彭晓蓉
    刘奎
    Science in China,SerB., 1994, Ser.B.1994 (03) : 271 - 279
  • [34] Regulation of plasminogen activator inhibitor-1 secretion by urokinase and tissue plasminogen activator in rat epithelioid-type smooth muscle cells
    Lau, HKF
    Ho, J
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (01) : 151 - 158
  • [35] Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy
    Lang, Hong
    Dai, Chun
    ARCHIVES OF MEDICAL RESEARCH, 2016, 47 (02) : 71 - 77
  • [36] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [37] Urokinase, tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis
    Sirén, V
    Kauhanen, P
    Carpén, O
    Luther, M
    Lepäntalo, M
    Vaheri, A
    Lassila, R
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (04) : 369 - 377
  • [38] JCAD enhances arterial thrombosis by regulating endothelial plasminogen activator inhibitor-1 and tissue factor expression
    Liberale, L.
    Akhmedov, A.
    Bonetti, N. R.
    Puspitasari, Y. M.
    Vukolic, A.
    Montecucco, F.
    Beer, J. H.
    Jin, Z. G.
    Liuzzo, G.
    Stellos, K.
    Crea, F.
    Luscher, T. F.
    Camici, G. G.
    EUROPEAN HEART JOURNAL, 2021, 42 : 3426 - 3426
  • [39] Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia
    Estellés, A
    Gilabert, J
    Grancha, S
    Yamamoto, K
    Thinnes, T
    España, F
    Aznar, J
    Loskutoff, DJ
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (03) : 500 - 508
  • [40] In-vitro effect of oncostatin M on the release by endothelial cells of von Willebrand factor, tissue-type plasminogen activator and plasminogen activator inhibitor-1
    Pourtau, J
    Soria, C
    Paysant, J
    Vannier, JP
    Vasse, M
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (07) : 609 - 615
12345